======= NR0B2 =======
== Gene Information ==
* **Official Symbol**: NR0B2
* **Official Name**: nuclear receptor subfamily 0 group B member 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8431|8431]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q15466|Q15466]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NR0B2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NR0B2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604630|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is an unusual orphan receptor that contains a putative ligand-binding domain but lacks a conventional DNA-binding domain. The gene product is a member of the nuclear hormone receptor family, a group of transcription factors regulated by small hydrophobic hormones, a subset of which do not have known ligands and are referred to as orphan nuclear receptors. The protein has been shown to interact with retinoid and thyroid hormone receptors, inhibiting their ligand-dependent transcriptional activation. In addition, interaction with estrogen receptors has been demonstrated, leading to inhibition of function. Studies suggest that the protein represses nuclear hormone receptor-mediated transactivation via two separate steps: competition with coactivators and the direct effects of its transcriptional repressor function. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Acts as a transcriptional regulator. Acts as a negative regulator of receptor-dependent signaling pathways. Specifically inhibits transactivation of the nuclear receptor with whom it interacts. Inhibits transcriptional activity of NEUROD1 on E-box- containing promoter by interfering with the coactivation function of the p300/CBP-mediated transcription complex for NEUROD1. {ECO:0000269|PubMed:14752053}.
|Hormone recep|
|peroxisome proliferator activated receptor binding|
|retinoid X receptor binding|
|thyroid hormone receptor binding|
|steroid hormone receptor activity|
|circadian regulation of gene expression|
|positive regulation of insulin secretion|
|animal organ regeneration|
|positive regulation of peptide hormone secretion|
|cholesterol metabolic process|
|steroid hormone mediated signaling pathway|
|Notch signaling pathway|
|positive regulation of hormone secretion|
|secondary alcohol metabolic process|
|sterol metabolic process|
|response to glucose|
|circadian rhythm|
|response to hexose|
|response to monosaccharide|
|regeneration|
|negative regulation of DNA-binding transcription factor activity|
|hormone-mediated signaling pathway|
|response to carbohydrate|
|transcription initiation from RNA polymerase II promoter|
|regulation of insulin secretion|
|cellular response to steroid hormone stimulus|
|regulation of peptide hormone secretion|
|DNA-templated transcription, initiation|
|transcription corepressor activity|
|protein domain specific binding|
|steroid metabolic process|
|protein-containing complex binding|
|regulation of hormone secretion|
|positive regulation of protein secretion|
|rhythmic process|
|positive regulation of peptide secretion|
|alcohol metabolic process|
|response to steroid hormone|
|transcription factor binding|
|positive regulation of secretion by cell|
|positive regulation of protein transport|
|regulation of DNA-binding transcription factor activity|
|positive regulation of secretion|
|organic hydroxy compound metabolic process|
|positive regulation of establishment of protein localization|
|regulation of protein secretion|
|transcription by RNA polymerase II|
|regulation of peptide secretion|
|cellular response to lipid|
|regulation of hormone levels|
|cellular response to organic cyclic compound|
|protein-containing complex|
|cellular response to hormone stimulus|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|regulation of protein transport|
|regulation of peptide transport|
|regulation of establishment of protein localization|
|regulation of secretion by cell|
|regulation of secretion|
|response to lipid|
|negative regulation of transcription by RNA polymerase II|
|protein homodimerization activity|
|response to hormone|
|response to organic cyclic compound|
|positive regulation of transport|
|regulation of protein localization|
|nucleobase-containing compound biosynthetic process|
|negative regulation of molecular function|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|negative regulation of transcription, DNA-templated|
|lipid metabolic process|
|cellular response to endogenous stimulus|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|organic cyclic compound biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|response to endogenous stimulus|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|response to oxygen-containing compound|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|negative regulation of gene expression|
|small molecule metabolic process|
|macromolecule biosynthetic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of transport|
|positive regulation of gene expression|
|gene expression|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5909
* **Expression level (log2 read counts)**: -5.6
{{:chemogenomics:nalm6 dist.png?nolink |}}